SubsidieMeestersPhotonic chip based high-throughput, multi-modal and scalable optical nanoscopy platform
NanoVision aims to revolutionize optical nanoscopy with an affordable, compact, and high-throughput photonic-chip solution, enhancing accessibility and flexibility for research and clinical labs.
Projectdetails
Introduction
The invention of super-resolution optical microscopy (nanoscopy) has given us a glimpse of its impact in all fields of science and medical care. Imagine the new scientific discoveries that can be realized if every research and clinical laboratory is equipped with an optical nanoscope that can deliver super-resolution imaging, enabling researchers a window to nanoscale biology.
Current Challenges
However, several pain points of the available solutions currently hinder wide-scale penetration of optical nanoscopy, such as:
- Cost
- Complexity
- Small throughput
- Limited flexibility in terms of choice of resolution and field-of-view (FOV)
Solution Overview
NanoVision will fill this pressing gap in the market with an affordable, compact, multi-modal, and high-throughput photonic-chip based optical nanoscopy. Present-day nanoscopes use a simple glass slide to hold the sample and a complex and bulky microscope set-up to illuminate and image.
Innovative Approach
We change the current paradigm to:
- Use a mass-producible photonic-chip to hold and illuminate the sample.
- Implement a simple and compact optical microscope to image it.
Our radical idea is thus to take out laser light steering and delivery from the microscope and transfer it to a photonic-chip.
Benefits of NanoVision
Photonic-chip based nanoscopy improves:
- Throughput by a factor of 100x
- Cost by a factor of 2x
- Flexibility in terms of resolution and FOV
These key differentiators of NanoVision will not only extend the present market of nanoscopy but could also open new market opportunities.
Development Status
Founded on two patent families, it has been brought up to TRL 4. A spin-off, Chip NanoImaging (CNI), has been incorporated.
Future Plans
NanoVision will propel the technology to TRL 6 by developing a user-friendly prototype and validating its impact during year-long user tests.
Financial Projections
The business and market development activities will enable us to attract investments of Euro 2M by 2024, with an estimated revenue of Euro 60M by 2029.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.489.571 |
| Totale projectbegroting | € 2.489.571 |
Tijdlijn
| Startdatum | 1-6-2022 |
| Einddatum | 31-5-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- CHIP NANOIMAGING ASpenvoerder
- UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET
- EUROPEAN MOLECULAR BIOLOGY LABORATORY
- KAROLINSKA INSTITUTET
Land(en)
Vergelijkbare projecten binnen EIC Transition
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Very High Energy Electrons Beam for RadiotherapyeBeam4Therapy aims to revolutionize cancer treatment by developing compact, cost-effective VHEE radiotherapy using laser plasma accelerators to improve patient outcomes and reduce side effects. | EIC Transition | € 2.477.043 | 2022 | Details |
High-throughput hyperspectral imaging across the VIS-SWIR spectrum in a single deviceThe HYPERIA project aims to develop a novel hyperspectral imaging camera using Fourier Transform interferometry for enhanced sensitivity and wavelength range, targeting applications in food safety and waste separation. | EIC Transition | € 1.500.000 | 2022 | Details |
Therapeutic Antisense Oligonucleotides Targeting NUMB Alternative Splicing in Lung AdenocarcinomaThis project aims to develop Antisense Oligonucleotides to correct pathological splicing of the NUMB gene in lung adenocarcinomas, improving treatment efficacy and paving the way for clinical trials. | EIC Transition | € 2.899.553 | 2022 | Details |
INCYPRO: A key technology to enable the broad application of proteins in diagnostics and therapeuticsThe INCYPROnext project aims to validate a novel technology for stabilizing proteins, enhancing their utility in biotechnological and biomedical applications, targeting a $170B market. | EIC Transition | € 2.498.750 | 2022 | Details |
Very High Energy Electrons Beam for Radiotherapy
eBeam4Therapy aims to revolutionize cancer treatment by developing compact, cost-effective VHEE radiotherapy using laser plasma accelerators to improve patient outcomes and reduce side effects.
High-throughput hyperspectral imaging across the VIS-SWIR spectrum in a single device
The HYPERIA project aims to develop a novel hyperspectral imaging camera using Fourier Transform interferometry for enhanced sensitivity and wavelength range, targeting applications in food safety and waste separation.
Therapeutic Antisense Oligonucleotides Targeting NUMB Alternative Splicing in Lung Adenocarcinoma
This project aims to develop Antisense Oligonucleotides to correct pathological splicing of the NUMB gene in lung adenocarcinomas, improving treatment efficacy and paving the way for clinical trials.
INCYPRO: A key technology to enable the broad application of proteins in diagnostics and therapeutics
The INCYPROnext project aims to validate a novel technology for stabilizing proteins, enhancing their utility in biotechnological and biomedical applications, targeting a $170B market.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Twisted nanophotonic technology for integrated chiroptical sensing of drugs on a chipTwistedNano aims to revolutionize drug discovery by developing integrated nanophotonic devices for ultrasensitive chiroptical spectroscopy on microfluidic chips, enhancing chiral sensing and diagnostics. | EIC Pathfinder | € 3.679.925 | 2022 | Details |
Nanoscale Isotropic 3D Resolution using Omni-view Structured Light Sheet MicroscopyThis project aims to revolutionize biological imaging by developing a novel optical architecture for super-resolution microscopy that enhances 3D imaging resolution and sample longevity without trade-offs. | ERC ADG | € 2.293.558 | 2022 | Details |
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technologyDISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI. | EIC Pathfinder | € 3.018.312 | 2022 | Details |
Nano electro-optomechanical programmable integrated circuitsNEUROPIC aims to develop a programmable photonic chip architecture for diverse applications, leveraging nanoelectromechanical technologies to enhance efficiency and enable neuromorphic computing. | EIC Pathfinder | € 2.999.924 | 2023 | Details |
Twisted nanophotonic technology for integrated chiroptical sensing of drugs on a chip
TwistedNano aims to revolutionize drug discovery by developing integrated nanophotonic devices for ultrasensitive chiroptical spectroscopy on microfluidic chips, enhancing chiral sensing and diagnostics.
Nanoscale Isotropic 3D Resolution using Omni-view Structured Light Sheet Microscopy
This project aims to revolutionize biological imaging by developing a novel optical architecture for super-resolution microscopy that enhances 3D imaging resolution and sample longevity without trade-offs.
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology
DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.
Nano electro-optomechanical programmable integrated circuits
NEUROPIC aims to develop a programmable photonic chip architecture for diverse applications, leveraging nanoelectromechanical technologies to enhance efficiency and enable neuromorphic computing.